Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 9, 1996, Pages 62-65

  Goldberg, Terry E ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT;

AMNESIA; ATTENTION; COGNITION; CONFERENCE PAPER; INTELLIGENCE QUOTIENT; MEMORY; PRIORITY JOURNAL; SCHIZOPHRENIA; WORKING MEMORY;

ANTIPSYCHOTIC AGENTS; ATTENTION; CLOZAPINE; COGNITION; HUMANS; INTELLIGENCE; MEMORY; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; WECHSLER SCALES;

EID: 0029842445     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Heaton RK, Crowley TJ. Effects of psychiatric disorders and their somatic treatment on neuropsychological test results. In: Filskov SB, Boll TJ, eds. Handbook of Clinical Neuropsychology. New York, NY: John Wiley; 1981:481-525
2. King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990;157:799-811
3. Medalia A, Gold J, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 1988;3: 249-271
4. Cassens G, Inglis AK, Appelbaum PS, et al. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 1990;16:477-490
5. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989; 98:367-380
6. Gold JM, Hurt SW. The effects of haloperidol on thought disorder and IQ in schizophrenia. J Pers Assess 1990;54:390-400
7. Kaufman AS. Assessing Adolescent and Adult Intelligence. Boston, Mass: Allyn and Bacon; 1990
8. Seidman LJ, Pepple JR, Faraone SV, et al. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biol Psychiatry 1993;33:575-584
9. Earle-Boyer EA, Serper MR, Davidson M, et al. Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance. Psychiatry Res 1991;37:47-56
10. Serper MR, Bergman RL, Harvey RD. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res 1990;32:281-288
11. Pigache RM. The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine. Schizophr Res 1993;10:39-50
12. Nestor PG, Fauz SF, McCarley RW, et al. Neuroleptics improve sustained attention in schizophrenia: a study using signal detection theory. Neuropsychophartnacology 1991;4:145-149
13. Cleghorn JM, Kaplan RD, Szechtman B, et al. Neuroleptic drug effects on cognitive function in schizophrenia. Schizophr Res 1990;3:211-219
14. Bilder RM, Turke E, Lipschutz-Broch L, et al. Antipsychotic medication effects on neuropsychological functions. Psychopharmacol Bull 1992;28: 353-366
15. Verdoux H, Magnin E, Bourgeois M. Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr Res 1995;14: 133-139
16. Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 1986;43: 126-135
17. Goldberg TE, Greenberg RD, Griffin SJ, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-48
18. Hagger C, Buckley P, Kenny JT, et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34:702-712
19. Buchanan RW, Holstein C, Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 1994;36:717-725
20. Goldberg TE, Gold JM. Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. London, England: Blackwell. In press
21. Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994;13:133-144
22. Meltzer HY, Cola P, Way L, et al. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 1993;150:1630-1638
23. Nuechterlein KH, Buchsbaum MS, Dawson ME. Neuropsychological vulnerability to schizophrenia. In: David AS, Cutting JC, eds. The Neuropsychology of Schizophrenia. Hove, England: Lawrence Erlbaum Associates; 1994:53-78